UPDATE: OPKO Health (OPK) Easily Tops Q3 Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
OPKO Announces Third Quarter Financial and Operating Results
November 9, 2015 4:13 PM ESTConsolidated Revenue Increased to $143.0 Million From $19.8 million for the Three Months Ended September 30, 2015, and Increased to $215.5 Million from $65.6 Million for the Nine Months Ended September 30, 2015 Closed Acquisition of Bio-Reference Laboratories on August 20, 2015 Announced Genomics Collaboration with Vanderbilt University School of Medicine 4Kscore® Blood Test to Identify Risk of Aggressive Prostate Cancer Included in the National Comprehensive Cancer Network Guidelines for Cancer Early Detection RayaldeeTM New Drug Application (NDA) Accepted by FDA; Expected PDUFA Date is March 29, 2016... More
